UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Microencapsulation of Fluticasone Propionate and Salmeterol Xinafoate in Modified Chitosan Microparticles for Release Optimization

Molecules (Basel, Switzerland), 2020-08, Vol.25 (17), p.3888

2020

Volltextzugriff (PDF)

Preclinical evaluation of novel synthesised nanoparticles based on tyrosine poly(ester amide) for improved targeted pulmonary delivery

Scientific reports, 2024-04, Vol.14 (1), p.9845-9845, Article 9845

2024

Volltextzugriff (PDF)

Molecular Dynamic Study of Mechanism Underlying Nature of Molecular Recognition and the Role of Crosslinker in the Synthesis of Salmeterol-Targeting Molecularly Imprinted Polymer for Analysis of Salmeterol Xinafoate in Biological Fluid

Molecules (Basel, Switzerland), 2022-06, Vol.27 (11), p.3619

2022

Volltextzugriff (PDF)

Bulk to Nanometer-Scale Infrared Spectroscopy of Pharmaceutical Dry Powder Aerosols

Analytical chemistry (Washington), 2020-06, Vol.92 (12), p.8323-8332

2020

Volltextzugriff (PDF)

Structural isomers of saligenin-based β2-agonists: synthesis and insight into the reaction mechanism

Organic & biomolecular chemistry, 2020-12, Vol.18 (47), p.9675-9688

2020

Volltextzugriff (PDF)

Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events

Cochrane database of systematic reviews, 2021-04, Vol.4 (4), p.CD007694

2021

Volltextzugriff (PDF)

Crystallographic Structure, Intermolecular Packing Energetics, Crystal Morphology and Surface Chemistry of Salmeterol Xinafoate (Form I)

Journal of pharmaceutical sciences, 2017-03, Vol.106 (3), p.882-891

2017

Volltextzugriff (PDF)

Utility of Von Pechman synthesis of coumarin reaction for development of spectrofluorimetric method for quantitation of salmeterol xinafoate in pharmaceutical preparations and human plasma

Luminescence (Chichester, England), 2018-08, Vol.33 (5), p.913-918

2018

Volltextzugriff (PDF)

Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results

Health technology assessment (Winchester, England), 2021-08, Vol.25 (51), p.1-70

2021

Volltextzugriff (PDF)

Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease

Cochrane database of systematic reviews, 2015-10 (10), p.CD008989-CD008989

2015

Volltextzugriff (PDF)

Cell membranes… and how long drugs may exert beneficial pharmacological activity in vivo

British journal of clinical pharmacology, 2016-09, Vol.82 (3), p.673-682

Vauquelin, Georges

2016

Volltextzugriff (PDF)

Beta‑2 Adrenergic Agonists Are Substrates and Inhibitors of Human Organic Cation Transporter 1

Molecular pharmaceutics, 2015-08, Vol.12 (8), p.2633-2641

2015

Volltextzugriff (PDF)

N-Desmethylclozapine, Fluoxetine, and Salmeterol Inhibit Postentry Stages of the Dengue Virus Life Cycle

Antimicrobial agents and chemotherapy, 2016-11, Vol.60 (11), p.6709-6718

2016

Volltextzugriff (PDF)

Comparative Efficacy of Umeclidinium/Vilanterol Versus Other Bronchodilators for the Treatment of Chronic Obstructive Pulmonary Disease: A Network Meta-Analysis

Advances in therapy, 2022-11, Vol.39 (11), p.4961-5010

2022

Volltextzugriff (PDF)

Measuring The Bipolar Charge Distributions of Fine Particle Aerosol Clouds of Commercial PMDI Suspensions Using a Bipolar Next Generation Impactor (bp-NGI)

Pharmaceutical research, 2019-01, Vol.36 (1), p.15-14, Article 15

2019

Volltextzugriff (PDF)

Indacaterol, a once-daily beta2-agonist, versus twice-daily beta₂-agonists or placebo for chronic obstructive pulmonary disease

Cochrane database of systematic reviews, 2015-01, Vol.1 (1), p.CD010139-CD010139

2015

Volltextzugriff (PDF)

Salmeterol, a Long‐Acting β2‐Adrenergic Receptor Agonist, Inhibits Macrophage Activation by Lipopolysaccharide From Porphyromonas gingivalis

Journal of periodontology (1970), 2017-07, Vol.88 (7), p.681-692

2017

Volltextzugriff (PDF)

Formulating powder–device combinations for salmeterol xinafoate dry powder inhalers

International journal of pharmaceutics, 2015-07, Vol.490 (1-2), p.360-367

2015

Volltextzugriff (PDF)

Predicting the Fine Particle Fraction of Dry Powder Inhalers Using Artificial Neural Networks

Journal of pharmaceutical sciences, 2017-01, Vol.106 (1), p.313-321

2017

Volltextzugriff (PDF)

Inhaled Long-Acting β2-Agonists Do Not Increase Fatal Cardiovascular Adverse Events in COPD: A Meta-Analysis

PloS one, 2015-09, Vol.10 (9), p.e0137904-e0137904

2015

Volltextzugriff (PDF)

Human Stimulus Factor Is a Promising Peptide for Delivery of Therapeutics

Journal of pharmaceutical sciences, 2019-04, Vol.108 (4), p.1401-1403

2019

Volltextzugriff (PDF)

In vitro studies on the behavior of salmeterol xinafoate and its interaction with calf thymus DNA by multi-spectroscopic techniques

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2014-11, Vol.132, p.198-204

2014

Volltextzugriff (PDF)

Enhanced oral bioavailability of salmeterol by loaded PLGA microspheres: preparation, in vitro, and in vivo evaluation

Drug delivery, 2016-01, Vol.23 (1), p.248-253

2016

Volltextzugriff (PDF)

Safety of Fluticasone Propionate Prescribed for Asthma During Pregnancy: A UK Population-Based Cohort Study

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2015-09, Vol.3 (5), p.772-779.e3

2015

Volltextzugriff (PDF)

An allosteric modulator binds to a conformational hub in the β 2 adrenergic receptor

Nature chemical biology, 2020-07, Vol.16 (7), p.749

2020

Volltextzugriff (PDF)

1 – 25 von 953

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(878)
Mit Volltextzugriff
(705)

Publikationsform

Sprache

10 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Salmeterol Xinafoate
(884)
Albuterol - Analogs & Derivatives
(808)
Humans
(785)
Science & Technology
(598)
Life Sciences & Biomedicine
(569)
Asthma - Drug Therapy
(431)
Albuterol - Therapeutic Use
(392)
Albuterol - Administration & Dosage
(277)
Administration, Inhalation
(271)
Bronchodilator Agents - Therapeutic Use
(266)
Fluticasone
(232)
Adrenergic Beta-Agonists - Therapeutic Use
(207)
Albuterol - Pharmacology
(205)
Respiratory System
(205)
General & Internal Medicine
(194)
Biological And Medical Sciences
(178)
Medical Sciences
(176)
Formoterol Fumarate
(175)
Bronchodilator Agents - Administration & Dosage
(173)
Drug Therapy, Combination
(172)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Microencapsulation of Fluticasone Propionate and Salmeterol Xinafoate in Modified Chitosan Microparticles for Release Optimization

Preclinical evaluation of novel synthesised nanoparticles based on tyrosine poly(ester amide) for improved targeted pulmonary delivery

Molecular Dynamic Study of Mechanism Underlying Nature of Molecular Recognition and the Role of Crosslinker in the Synthesis of Salmeterol-Targeting Molecularly Imprinted Polymer for Analysis of Salmeterol Xinafoate in Biological Fluid

Bulk to Nanometer-Scale Infrared Spectroscopy of Pharmaceutical Dry Powder Aerosols

Structural isomers of saligenin-based β2-agonists: synthesis and insight into the reaction mechanism

Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events

Crystallographic Structure, Intermolecular Packing Energetics, Crystal Morphology and Surface Chemistry of Salmeterol Xinafoate (Form I)

Utility of Von Pechman synthesis of coumarin reaction for development of spectrofluorimetric method for quantitation of salmeterol xinafoate in pharmaceutical preparations and human plasma

Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results

Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease

Cell membranes… and how long drugs may exert beneficial pharmacological activity in vivo

Beta‑2 Adrenergic Agonists Are Substrates and Inhibitors of Human Organic Cation Transporter 1

N-Desmethylclozapine, Fluoxetine, and Salmeterol Inhibit Postentry Stages of the Dengue Virus Life Cycle

Comparative Efficacy of Umeclidinium/Vilanterol Versus Other Bronchodilators for the Treatment of Chronic Obstructive Pulmonary Disease: A Network Meta-Analysis

Measuring The Bipolar Charge Distributions of Fine Particle Aerosol Clouds of Commercial PMDI Suspensions Using a Bipolar Next Generation Impactor (bp-NGI)

Indacaterol, a once-daily beta2-agonist, versus twice-daily beta₂-agonists or placebo for chronic obstructive pulmonary disease

Salmeterol, a Long‐Acting β2‐Adrenergic Receptor Agonist, Inhibits Macrophage Activation by Lipopolysaccharide From Porphyromonas gingivalis

Formulating powder–device combinations for salmeterol xinafoate dry powder inhalers

Predicting the Fine Particle Fraction of Dry Powder Inhalers Using Artificial Neural Networks

Inhaled Long-Acting β2-Agonists Do Not Increase Fatal Cardiovascular Adverse Events in COPD: A Meta-Analysis

Human Stimulus Factor Is a Promising Peptide for Delivery of Therapeutics

In vitro studies on the behavior of salmeterol xinafoate and its interaction with calf thymus DNA by multi-spectroscopic techniques

Enhanced oral bioavailability of salmeterol by loaded PLGA microspheres: preparation, in vitro, and in vivo evaluation

Safety of Fluticasone Propionate Prescribed for Asthma During Pregnancy: A UK Population-Based Cohort Study

An allosteric modulator binds to a conformational hub in the β 2 adrenergic receptor

Aktive Filter

Suchergebnisse filtern